79 related articles for article (PubMed ID: 20214304)
1. [Treatment of hepatitis C in patients with extrahepatic diseases].
Bessone F; Fernández N; Frider B
Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S53-5. PubMed ID: 20214304
[No Abstract] [Full Text] [Related]
2. [Organic nephropathies in patients with liver diseases].
Amoedo ML; Montoliu J
Gastroenterol Hepatol; 1996 Mar; 19(3):167-77. PubMed ID: 8991663
[No Abstract] [Full Text] [Related]
3. Regression of splenic lymphoma after treatment of hepatitis C virus infection.
Mazzaro C; Little D; Pozzato G
N Engl J Med; 2002 Dec; 347(26):2168-70; author reply 2168-70. PubMed ID: 12501232
[No Abstract] [Full Text] [Related]
4. Autoimmune disorders associated with hepatitis C.
Marcellin P; Benhamou JP
Prog Liver Dis; 1995; 13():247-67. PubMed ID: 9224505
[No Abstract] [Full Text] [Related]
5. Porphyria cutanea tarda, dermatomyositis and non-Hodgkin lymphoma in virus C infection.
Bauzá A; España A; Lloret P
Eur J Dermatol; 2003; 13(3):302-4. PubMed ID: 12804996
[TBL] [Abstract][Full Text] [Related]
6. [When should hepatitis C serology be required in dermatology?].
Dupin N; Chosidow O; Lunel F; Francès C
Ann Dermatol Venereol; 1994; 121(8):574-8. PubMed ID: 7538742
[No Abstract] [Full Text] [Related]
7. [Treatment of hepatitis C virus associated extrahepatic manifestations].
Duclos-Vallée JC
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B76-81. PubMed ID: 12180311
[No Abstract] [Full Text] [Related]
8. HCV infection and extrahepatic manifestations.
Nocente R; Ceccanti M; Bertazzoni G; Cammarota G; Silveri NG; Gasbarrini G
Hepatogastroenterology; 2003; 50(52):1149-54. PubMed ID: 12846002
[TBL] [Abstract][Full Text] [Related]
9. [Cryoglobulinemia in chronic liver diseases: cause or consequence?].
Csepregi A; Nemesánszky E
Orv Hetil; 1997 Mar; 138(11):651-6. PubMed ID: 9102622
[TBL] [Abstract][Full Text] [Related]
10. [Extrahepatic manifestations in hepatitis C. Are they overlooked?].
Kristiansen MG; Florholmen J
Tidsskr Nor Laegeforen; 2001 Feb; 121(4):446-9. PubMed ID: 11255860
[TBL] [Abstract][Full Text] [Related]
11. [Extrahepatic manifestations of hepatitis C virus].
Yuste JR; Beloqui O; Garcia N; Prieto J
An Med Interna; 1995 Dec; 12(12):609-16. PubMed ID: 8679807
[No Abstract] [Full Text] [Related]
12. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
13. [Extrahepatic manifestations of hepatitis C infection].
Rambusch EG; Manns MP
Z Gastroenterol; 1998 Jul; 36(7):579-86. PubMed ID: 9738306
[TBL] [Abstract][Full Text] [Related]
14. Regression of splenic lymphoma after treatment of hepatitis C virus infection.
Agnello V; Mecucci C; Casato M
N Engl J Med; 2002 Dec; 347(26):2168-70; author reply 2168-70. PubMed ID: 12501854
[No Abstract] [Full Text] [Related]
15. Hepatitis C-associated autoimmunity in patients coinfected with HIV.
Woitas RP; Stoschus B; Terjung B; Vogel M; Kupfer B; Brackmann HH; Rockstroh JK; Sauerbruch T; Spengler U
Liver Int; 2005 Dec; 25(6):1114-21. PubMed ID: 16343060
[TBL] [Abstract][Full Text] [Related]
16. Extrahepatic manifestations of hepatitis C virus infection.
Zignego AL; Craxì A
Clin Liver Dis; 2008 Aug; 12(3):611-36, ix. PubMed ID: 18625431
[TBL] [Abstract][Full Text] [Related]
17. [Interferon and cryoglobulinemia: how to inject without precipitation].
Touraud JP; Dalac S; Dutronc Y; Hillon P; Sgro C; Lambert D
Gastroenterol Clin Biol; 2000; 24(8-9):854-5. PubMed ID: 11011266
[No Abstract] [Full Text] [Related]
18. Hepatitis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin's lymphoma.
Germanidis G; haioun C; Dhumeaux D; Reyes F; Pawlotsky JM
Hepatology; 1999 Sep; 30(3):822-3. PubMed ID: 10490376
[No Abstract] [Full Text] [Related]
19. Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al.
De Vita S; Quartuccio L
Arthritis Rheum; 2010 Mar; 62(3):908-9; author reply 909. PubMed ID: 20131242
[No Abstract] [Full Text] [Related]
20. Cutaneous vasculitis and cryoglobulinaemia type II associated with hepatitis C virus infection.
Durand JM; Lefevre P; Harle JR; Boucrat J; Vitviski L; Soubeyrand J
Lancet; 1991 Feb; 337(8739):499-500. PubMed ID: 1671507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
